These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1290622)

  • 1. Uses of biological markers.
    Lerner AJ; Friedland RP; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1992; 6(4):197-200. PubMed ID: 1290622
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistological study on the distribution of alpha 1-antichymotrypsin in Alzheimer's brain, compared to beta-amyloid precursor protein and beta-amyloid protein.
    Takahashi H; Hirokawa K; Tsukagoshi H
    J Neurol Sci; 1990 Nov; 99(2-3):301-10. PubMed ID: 2128319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Alzheimer disease-the challenges ahead.
    Sperling RA; Karlawish J; Johnson KA
    Nat Rev Neurol; 2013 Jan; 9(1):54-8. PubMed ID: 23183885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers in Alzheimer's disease.
    Grundke-Iqbal I; Rolkova G; Konstekova E; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):359-65. PubMed ID: 17262988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers for the clinical diagnosis of Alzheimer's disease.
    Arai H
    Tohoku J Exp Med; 1996 Jun; 179(2):65-79. PubMed ID: 8875763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
    Lehmann S; Delaby C; Paquet C; Gabelle A
    Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's: forestalling the darkness.
    Stix G
    Sci Am; 2010 Jun; 302(6):50-7. PubMed ID: 20521480
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid.
    Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S; Takatama M
    Prog Clin Biol Res; 1989; 317():1049-59. PubMed ID: 2690085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.
    Abraham CR; Shirahama T; Potter H
    Neurobiol Aging; 1990; 11(2):123-9. PubMed ID: 2190106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biomarkers in clinical trials for Alzheimer disease.
    Thal LJ; Kantarci K; Reiman EM; Klunk WE; Weiner MW; Zetterberg H; Galasko D; Praticò D; Griffin S; Schenk D; Siemers E
    Alzheimer Dis Assoc Disord; 2006; 20(1):6-15. PubMed ID: 16493230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers reflecting different facets of Alzheimer's disease.
    Zetterberg H
    Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biomarker and imaging of Alzheimer's disease].
    Kawarabayashi T; Shoji M
    No To Shinkei; 2005 Oct; 57(10):839-52. PubMed ID: 16277229
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
    Morris JC; Selkoe DJ
    Neurobiol Aging; 2011 Dec; 32 Suppl 1():S1-3. PubMed ID: 22078168
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of genome mutation and Alzheimer's disease.
    Thomas P; Fenech M
    Mutagenesis; 2007 Jan; 22(1):15-33. PubMed ID: 17158517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers and gene mutations as aids for detecting AD early.
    Grandy JK
    JAAPA; 2011 Jun; 24(6):56-7. PubMed ID: 21682178
    [No Abstract]   [Full Text] [Related]  

  • 16. [Markers of prodromal Alzheimer's disease].
    de Souza LC; Sarazin M; Uspenskaya O; Habert MO; Lamari F; Lehéricy S; Dubois B
    Rev Neurol (Paris); 2012 Nov; 168(11):815-24. PubMed ID: 22944619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.
    Wiltfang J; Esselmann H; Maler JM; Bleich S; Hüther G; Kornhuber J
    Gerontology; 2001; 47(2):65-71. PubMed ID: 11287729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of alpha 1-antichymotrypsin in the aged human brain.
    Ishiguro K; Shoji M; Yamaguchi H; Matsubara E; Ikeda M; Kawarabayashi T; Harigaya Y; Okamoto K; Hirai S
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):221-7. PubMed ID: 8287118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Biomarkers Predict Brain Amyloid-β Burden.
    Abbasi J
    JAMA; 2018 Mar; 319(10):972. PubMed ID: 29536076
    [No Abstract]   [Full Text] [Related]  

  • 20. The utility of the new research diagnostic criteria for Alzheimer's disease.
    Dubois B; Gauthier S; Cummings J
    Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.